Report Screener | Stock Screener | Bond Screener | Fund Screener

Report Search Results (Showing 1 to 13 of 13)As of 24-Nov-2009
New Screen 

All Reports | Brokerage Reports | Independent Reports
Release
Date [down]		 Contributor Author Title Pages Price StarMine Author Rating More Info
EPS Accuracy * Portfolio Return **
13-Nov-09Williams Capital Group, L.P.Beth SenkoUnitedHealth Group — Cutting Enrollment/Revenue Estimates Due to Economic Concerns9$25  View Abstract
6-Nov-09Williams Capital Group, L.P.Beth SenkoSymmetry Medical (SMA) — Looking to 2006 for a Run Rate — Cutting Estimates5$10  View Abstract
30-Oct-09Williams Capital Group, L.P.Beth SenkoCoventry Health Care (CVH) — Top Line Growth Remains Key8$25  View Abstract
30-Oct-09Williams Capital Group, L.P.Beth SenkoWright Medical Group — An Upside Sales Surprise — Raising Estimates7$25  View Abstract
30-Oct-09Williams Capital Group, L.P.Beth SenkoSymmetry Medical (SMA) — It’s Not 2006 All Over Again, or Is It?5$10  View Abstract
29-Oct-09Williams Capital Group, L.P.Beth SenkoSpectranetics (SPNC) — Still Unsure if The Focus is There — Trimming Estimates6$25  View Abstract
29-Oct-09Williams Capital Group, L.P.Beth SenkoWellpoint, Inc. (WLP) — Headwinds and Tailwinds for 20107$25  View Abstract
28-Oct-09Williams Capital Group, L.P.Beth SenkoWright Medical Group (WMGI) — Looking Ahead to 3Q09 Results7$25  View Abstract
28-Oct-09Williams Capital Group, L.P.Beth SenkoeV3, Inc. (EVVV) — Neurovascular Accelerates — Costs Better Than Expected6$25  View Abstract
26-Oct-09Williams Capital Group, L.P.Beth SenkoWellpoint, Inc. (WLP) — Looking Ahead to 3Q09 Results7$25  View Abstract
26-Oct-09Williams Capital Group, L.P.Beth SenkoCoventry Health Care (CVH) — Guidance May Increase, But Top-Line is Long-term Key9$25  View Abstract
21-Oct-09Williams Capital Group, L.P.Beth SenkoUnitedHealth Group (UNH) — On One Hand — On the Other — Cutting Estimates8$25  View Abstract
19-Oct-09Williams Capital Group, L.P.Beth SenkoUnitedHealth Group (UNH) — Looking Ahead to 3Q09 Results9$25  View Abstract

* EPS Accuracy is a measure of an analyst's ability to accurately estimate the EPS for a company.
** Portfolio Return is a measure of the performance of an analyst's recommendations relative to his peers.

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.